2022
DOI: 10.7717/peerj.14590
|View full text |Cite
|
Sign up to set email alerts
|

Genetic analysis of DNA methylation in dyslipidemia: a case-control study

Abstract: Background Coronary heart disease has become the leading cause of death in developed countries, and dyslipidemia is closely associated with the risk of cardiovascular disease. Dyslipidemia is caused by the abnormal regulation of several genes and signaling pathways, and dyslipidemia is influenced mainly by genetic variation. AMFR, FBXW7, INSIG1, INSIG2, and MBTPS1 genes are associated with lipid metabolism. In a recent GWAS study, the GRINA gene has been reported to be associated with dyslipidemia, but its mol… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(1 citation statement)
references
References 55 publications
0
0
0
Order By: Relevance
“…It plays a pivotal role in the recognition of misfolded proteins, marking them for ubiquitination and subsequent degradation by the proteasome through the endoplasmic reticulum-associated degradation (ERAD) pathway. This process prevents the accumulation of misfolded proteins within the endoplasmic reticulum lumen, thereby maintaining the integrity of the secretory pathway, an essential protective mechanism in vivo ( 47 ). In this study, we present the first evidence that AMFR may lower the incidence of AF and explore the expression profile of AMFR to elucidate its mechanism of action in AF further.…”
Section: Discussionmentioning
confidence: 99%
“…It plays a pivotal role in the recognition of misfolded proteins, marking them for ubiquitination and subsequent degradation by the proteasome through the endoplasmic reticulum-associated degradation (ERAD) pathway. This process prevents the accumulation of misfolded proteins within the endoplasmic reticulum lumen, thereby maintaining the integrity of the secretory pathway, an essential protective mechanism in vivo ( 47 ). In this study, we present the first evidence that AMFR may lower the incidence of AF and explore the expression profile of AMFR to elucidate its mechanism of action in AF further.…”
Section: Discussionmentioning
confidence: 99%